Celldex Therapeutics, Inc. Proceeds from Sale of Productive Assets
Celldex Therapeutics, Inc. (CLDX) reported Proceeds from Sale of Productive Assets of $69.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2025-02-27
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for the quarter ending 2022-09-30 was $69.00K, a 6800.00% increase year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for the quarter ending 2021-12-31 was $2.00K, a 92.31% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for the quarter ending 2021-09-30 was $1.00K, a 88.89% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2022 was $69.00K, a 155.56% increase from fiscal 2021.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2021 was $27.00K, a 50.91% decline from fiscal 2020.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2020 was $55.00K, a 175.00% increase from fiscal 2019.
- Celldex Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2019 was $20.00K, a 94.15% decline from fiscal 2018.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $69.00K derived: sum of 2 quarters · filed 2025-02-27 | $69.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $69.00K 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | |||
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $3.00K derived: sum of 2 quarters · filed 2024-02-26 | $3.00K derived: sum of 3 quarters · filed 2024-02-26 | $27.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.00K derived: sum of 2 quarters · filed 2022-11-09 | $25.00K 10-Q · filed 2022-11-09 | $51.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $24.00K 10-Q · filed 2022-08-08 | $50.00K derived: sum of 3 quarters · filed 2023-02-28 | $59.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-05 | $50.00K derived: sum of 2 quarters · filed 2023-02-28 | $59.00K derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $35.00K derived: sum of 2 quarters · filed 2023-02-28 | $55.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $29.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $20.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $20.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $20.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $342.00K 10-K · filed 2021-03-29 | ||
| 2018-09-30 | $342.00K 10-Q · filed 2019-11-12 | |||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $21.00K 10-K/A · filed 2016-02-25 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $21.00K 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $21.00K 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $62.00K derived: sum of 2 quarters · filed 2015-02-24 | $207.00K derived: sum of 3 quarters · filed 2015-02-24 | $218.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $207.00K derived: sum of 2 quarters · filed 2013-11-08 | $218.00K 10-Q · filed 2013-11-08 | $218.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $156.00K 10-Q · filed 2013-08-06 | $156.00K derived: sum of 3 quarters · filed 2014-03-03 | $160.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $11.00K 10-Q · filed 2013-05-03 | $11.00K derived: sum of 2 quarters · filed 2014-03-03 | $15.00K derived: sum of 3 quarters · filed 2014-03-03 | $15.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $4.00K derived: sum of 2 quarters · filed 2014-03-03 | $4.00K derived: sum of 3 quarters · filed 2014-03-03 | $68.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $4.00K derived: sum of 2 quarters · filed 2012-11-02 | $68.00K 10-Q · filed 2012-11-02 | $95.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $64.00K 10-Q · filed 2012-08-09 | $91.00K derived: sum of 3 quarters · filed 2013-03-08 | |
| 2011-03-31 | $64.00K 10-Q · filed 2012-05-04 | $91.00K derived: sum of 2 quarters · filed 2013-03-08 | ||
| 2010-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $77.00K 10-K · filed 2013-03-08 | ||
| 2010-09-30 | $50.00K 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | $850.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |